HRP20030653B1 - Novel benzoylguanidine salt - Google Patents

Novel benzoylguanidine salt

Info

Publication number: HRP20030653B1
Authority: HR; Croatia
Prior art keywords: salt; novel; novel benzoylguanidine; benzoylguanidine salt; benzoylguanidine
Prior art date: 2001-02-15

Application number

HRP20030653AA

Other languages

English (en)

Croatian (hr)

Inventor

Eickmeier Christian

Sieger Peter

K�rner Volkmar

Herter Rolf

Rall Werner

Original Assignee

Boehringer Ingelheim Pharma Gmbh & Co.Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-15

Filing date

2002-02-14

Publication date

2012-06-30

2002-02-14 Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg

2005-06-30 Publication of HRP20030653A2 publication Critical patent/HRP20030653A2/hr

2012-06-30 Publication of HRP20030653B1 publication Critical patent/HRP20030653B1/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/40—2,5-Pyrrolidine-diones
- C07D207/416—2,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Diabetes (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Pulmonology (AREA)
Obesity (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Endocrinology (AREA)
Hematology (AREA)
Emergency Medicine (AREA)
Surgery (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrrole Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

HRP20030653AA 2001-02-15 2002-02-14 Novel benzoylguanidine salt HRP20030653B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10106970A DE10106970A1 (de)	2001-02-15	2001-02-15	Neues Benzoylguanidinsalz
PCT/EP2002/001535 WO2002064563A1 (de)	2001-02-15	2002-02-14	Neues benzoylguanidinsalz

Publications (2)

Publication Number	Publication Date
HRP20030653A2 HRP20030653A2 (en)	2005-06-30
HRP20030653B1 true HRP20030653B1 (en)	2012-06-30

Family

ID=7674094

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HRP20030653AA HRP20030653B1 (en)	2001-02-15	2002-02-14	Novel benzoylguanidine salt

Country Status (31)

Country	Link
US (2)	US20080025919A1 (cs)
EP (1)	EP1362030B1 (cs)
JP (3)	JP4408626B2 (cs)
KR (1)	KR100862176B1 (cs)
CN (1)	CN1222510C (cs)
AT (1)	ATE553078T1 (cs)
AU (1)	AU2002250939B2 (cs)
BG (1)	BG66330B1 (cs)
BR (1)	BR0207867A (cs)
CA (1)	CA2434829C (cs)
CY (1)	CY1112878T1 (cs)
CZ (1)	CZ303277B6 (cs)
DE (1)	DE10106970A1 (cs)
DK (1)	DK1362030T3 (cs)
EA (1)	EA006245B1 (cs)
EC (1)	ECSP034708A (cs)
EE (1)	EE200300393A (cs)
ES (1)	ES2385472T3 (cs)
HR (1)	HRP20030653B1 (cs)
HU (1)	HU230035B1 (cs)
IL (1)	IL156934A (cs)
NO (1)	NO20033299L (cs)
NZ (1)	NZ528081A (cs)
PL (1)	PL213300B1 (cs)
PT (1)	PT1362030E (cs)
RS (1)	RS52014B (cs)
SI (1)	SI1362030T1 (cs)
SK (1)	SK287830B6 (cs)
UA (1)	UA74625C2 (cs)
WO (1)	WO2002064563A1 (cs)
ZA (1)	ZA200305365B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10106970A1 (de) *	2001-02-15	2002-08-29	Boehringer Ingelheim Pharma	Neues Benzoylguanidinsalz
US6982256B2 (en)	2001-09-07	2006-01-03	Boehringer Ingelheim Pharma Kg	Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration
DE10144030A1 (de) *	2001-09-07	2003-03-27	Boehringer Ingelheim Pharma	Verbesserung der lokalen Verträglichkeit bei intravenöser Verabreichung von 4-(4-(2-Pyrrolylcarbonyl-1-piperazinyl)-3-trifluormethyl-benzoylguanidin
US20110118262A1 (en) *	2008-07-08	2011-05-19	Boehringer Ingelheim International Gmbh	Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors
WO2015160820A1 (en) *	2014-04-14	2015-10-22	The University Of Memphis	Wireless analog passive sensors
US12369831B1 (en)	2018-04-30	2025-07-29	Bashir I. Morshed	Apparatus and method to capture body signals with conjugate coils and paired coils

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000017176A2 (de) *	1998-09-22	2000-03-30	Boehringer Ingelheim Pharma Kg	Benzolylguanidin-abkömmlinge mit vorteilhaften eigenschaften, verfahren zu ihrer herstellung und ihre verwendung bei der herstellung von arzneimiteln

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19601303A1 (de) *	1996-01-16	1997-07-17	Boehringer Ingelheim Kg	Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln
US6323207B1 (en) *	1998-09-22	2001-11-27	Boehringer Ingelheim Pharma Kg	Benzoylguanidine derivatives
DE10106970A1 (de) *	2001-02-15	2002-08-29	Boehringer Ingelheim Pharma	Neues Benzoylguanidinsalz
US6730678B2 (en) *	2001-02-15	2004-05-04	Boehringer Ingelheim Pharma Kg	Benzoylguanidine salt and hydrates thereof

2001
- 2001-02-15 DE DE10106970A patent/DE10106970A1/de not_active Ceased
2002
- 2002-02-14 EE EEP200300393A patent/EE200300393A/xx unknown
- 2002-02-14 ES ES02719831T patent/ES2385472T3/es not_active Expired - Lifetime
- 2002-02-14 AT AT02719831T patent/ATE553078T1/de active
- 2002-02-14 PT PT02719831T patent/PT1362030E/pt unknown
- 2002-02-14 AU AU2002250939A patent/AU2002250939B2/en not_active Ceased
- 2002-02-14 CN CNB028049926A patent/CN1222510C/zh not_active Expired - Fee Related
- 2002-02-14 EP EP02719831A patent/EP1362030B1/de not_active Expired - Lifetime
- 2002-02-14 EA EA200300771A patent/EA006245B1/ru not_active IP Right Cessation
- 2002-02-14 IL IL15693402A patent/IL156934A/en not_active IP Right Cessation
- 2002-02-14 SI SI200230982T patent/SI1362030T1/sl unknown
- 2002-02-14 HU HU0303027A patent/HU230035B1/hu not_active IP Right Cessation
- 2002-02-14 UA UA2003098454A patent/UA74625C2/uk unknown
- 2002-02-14 SK SK1020-2003A patent/SK287830B6/sk not_active IP Right Cessation
- 2002-02-14 WO PCT/EP2002/001535 patent/WO2002064563A1/de not_active Ceased
- 2002-02-14 KR KR1020037010723A patent/KR100862176B1/ko not_active Expired - Fee Related
- 2002-02-14 PL PL362129A patent/PL213300B1/pl unknown
- 2002-02-14 CA CA002434829A patent/CA2434829C/en not_active Expired - Fee Related
- 2002-02-14 HR HRP20030653AA patent/HRP20030653B1/xx not_active IP Right Cessation
- 2002-02-14 JP JP2002564496A patent/JP4408626B2/ja not_active Expired - Fee Related
- 2002-02-14 DK DK02719831.6T patent/DK1362030T3/da active
- 2002-02-14 RS YU61503A patent/RS52014B/sr unknown
- 2002-02-14 CZ CZ20032210A patent/CZ303277B6/cs not_active IP Right Cessation
- 2002-02-14 BR BR0207867-8A patent/BR0207867A/pt not_active Application Discontinuation
- 2002-02-14 NZ NZ528081A patent/NZ528081A/en not_active IP Right Cessation
2003
- 2003-07-11 ZA ZA200305365A patent/ZA200305365B/en unknown
- 2003-07-22 NO NO20033299A patent/NO20033299L/no not_active Application Discontinuation
- 2003-07-29 EC EC2003004708A patent/ECSP034708A/es unknown
- 2003-08-06 BG BG108065A patent/BG66330B1/bg unknown
2007
- 2007-08-21 US US11/842,941 patent/US20080025919A1/en not_active Abandoned
2008
- 2008-06-06 US US12/134,245 patent/US20080241077A1/en not_active Abandoned
2009
- 2009-07-15 JP JP2009166773A patent/JP5745215B2/ja not_active Expired - Fee Related
2012
- 2012-07-06 CY CY20121100605T patent/CY1112878T1/el unknown
2013
- 2013-03-08 JP JP2013047091A patent/JP2013107906A/ja not_active Withdrawn

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000017176A2 (de) *	1998-09-22	2000-03-30	Boehringer Ingelheim Pharma Kg	Benzolylguanidin-abkömmlinge mit vorteilhaften eigenschaften, verfahren zu ihrer herstellung und ihre verwendung bei der herstellung von arzneimiteln

Also Published As

Publication number	Publication date
JP2009235097A (ja)	2009-10-15
ATE553078T1 (de)	2012-04-15
JP4408626B2 (ja)	2010-02-03
HRP20030653A2 (en)	2005-06-30
EE200300393A (et)	2003-12-15
PL362129A1 (en)	2004-10-18
BR0207867A (pt)	2004-03-23
RS52014B (sr)	2012-04-30
JP2013107906A (ja)	2013-06-06
HK1064093A1 (zh)	2005-01-21
CZ20032210A3 (cs)	2003-12-17
EA006245B1 (ru)	2005-10-27
NO20033299D0 (no)	2003-07-22
NO20033299L (no)	2003-07-22
KR20030075197A (ko)	2003-09-22
BG66330B1 (bg)	2013-06-28
WO2002064563A1 (de)	2002-08-22
ES2385472T3 (es)	2012-07-25
DK1362030T3 (da)	2012-07-09
US20080025919A1 (en)	2008-01-31
SK10202003A3 (sk)	2004-02-03
UA74625C2 (en)	2006-01-16
JP2004518721A (ja)	2004-06-24
KR100862176B1 (ko)	2008-10-09
HUP0303027A3 (en)	2010-04-28
AU2002250939B2 (en)	2007-09-06
ECSP034708A (es)	2003-12-24
CA2434829A1 (en)	2002-08-22
EP1362030A1 (de)	2003-11-19
DE10106970A1 (de)	2002-08-29
CZ303277B6 (cs)	2012-07-11
YU61503A (sh)	2006-05-25
CY1112878T1 (el)	2016-04-13
CA2434829C (en)	2009-12-08
US20080241077A1 (en)	2008-10-02
PL213300B1 (pl)	2013-02-28
JP5745215B2 (ja)	2015-07-08
CN1491213A (zh)	2004-04-21
NZ528081A (en)	2005-10-28
HUP0303027A2 (hu)	2003-12-29
CN1222510C (zh)	2005-10-12
BG108065A (bg)	2005-01-31
IL156934A0 (en)	2004-02-08
SI1362030T1 (sl)	2012-07-31
EP1362030B1 (de)	2012-04-11
EA200300771A1 (ru)	2004-02-26
PT1362030E (pt)	2012-07-04
IL156934A (en)	2005-12-18
SK287830B6 (sk)	2011-11-04
ZA200305365B (en)	2004-04-22
HU230035B1 (hu)	2015-05-28

Legal Events

Date	Code	Title	Description
2005-06-30	A1OB	Publication of a patent application
2005-12-27	ARAI	Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
2012-06-30	B1PR	Patent granted
2016-02-02	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20160202 Year of fee payment: 15
2017-08-30	PBON	Lapse due to non-payment of renewal fee	Effective date: 20170214

Publication	Publication Date	Title
ATE363463T1 (de)	2007-06-15	2-(2,6-dichlorphenyl)-diarylimidazole
DK0931788T3 (da)	2002-11-25	Metalloproteasehæmmere
CY1113578T1 (el)	2016-06-22	2,3-διυδρο-6-νιτροϊμιδαζο 2,1 -b-οξαζολια
NO20040933L (no)	2004-03-03	Nye gamma-sekretaseinhibitorer.
DK1385515T3 (da)	2008-10-27	Spiropyrazole forbindelser
DK1414803T3 (da)	2013-03-25	Pyrazolylcarboxanilider som fungicider
WO2004018449A8 (en)	2004-05-06	Piperidine-derivatives as pde4 inhibitors
ATE552834T1 (de)	2012-04-15	Zubereitung von 1,6-disubstituierten azabenzimidazolen als kinasehemmer
MXPA05001354A (es)	2005-04-28	Piperidina-ftalazonas sustituidas por pirrolidinodiona como inhibidores pde4.
DK1379239T3 (da)	2008-01-07	N(2-aryl-ethyl)-benzyl-aminer som antagonister af 5 HT6 receptoren
NO20041075L (no)	2004-03-15	Ny 1, 2, 4-triazolforbindelse
BR0116217A (pt)	2003-12-30	Quinolonas antimicrobianas, composição farmacêutica, bem como aplicação farmacêutica das referidas quinolonas
SE0004245D0 (sv)	2000-11-20	Novel compounds and their use
EA200301100A1 (ru)	2004-06-24	Новые фталазиноны
ATE511352T1 (de)	2011-06-15	Antimikrobielle zusammensetzungen
HRP20080057T3 (en)	2008-02-29	9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
SE0103710D0 (sv)	2001-11-07	Compounds
NO20054787L (no)	2005-11-14	Indenderivater som farmasotiske midler
DK1330458T3 (da)	2009-09-21	N-(1,2,4-triazoloazinyl)thiophensulfonamidforbindelser som herbicider
SV2003000981A (es)	2003-07-29	Fenil-heterociclil-eteres ref. pcs10973
DK1532111T3 (da)	2007-10-22	2,5-disubstitueret 3-mercaptopentansyre
EA200301101A1 (ru)	2004-04-29	Производные пиперазина и их применение в качестве ингибиторов pde4
NO20023951L (no)	2002-08-20	Arylpiperaziner og arylpiperidiner og deres anvendelse som metalloproteinaseinhiberende midler
NO20035431D0 (no)	2003-12-05	Nye forbindelser som er nyttige i reflukssykdom
EA200300771A1 (ru)	2004-02-26	Новая соль бензоилгуанидина